Page last updated: 2024-12-07

aerobactin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123762
CHEBI ID18157
SCHEMBL ID404110
MeSH IDM0099723

Synonyms (17)

Synonym
(8s,16s)-3,12,21-trihydroxy-2,10,14,22-tetraoxo-3,9,15,21-tetraazatricosane-8,12,16-tricarboxylic acid
n(2),n(2)'-(3-carboxy-3-hydroxypentanedioyl)bis(n(6)-acetyl-n(6)-hydroxy-l-lysine)
CHEBI:18157
C05554
aerobactin ,
26198-65-2
3,9,15,21-tetraazatricosane-8,12,16-tricarboxylic acid, 3,12,21-trihydroxy-2,10,14,22-tetraoxo-, [s-(r*,r*)]-
ferric-aerobactin
3,9,15,21-tetraazatricosane-8,12,16-tricarboxylic acid, 3,12,21-trihydroxy-2,10,14,22-tetraoxo-, (s-(r*,r*))-
SCHEMBL404110
(2s)-2-[3-carboxy-3-({[(1s)-1-carboxy-5-(n-hydroxyacetamido)pentyl]carbamoyl}methyl)-3-hydroxypropanamido]-6-(n-hydroxyacetamido)hexanoic acid
DTXSID90904341
Q2875340
4-[[(1s)-5-[acetyl(hydroxy)amino]-1-carboxypentyl]amino]-2-[2-[[(1s)-5-[acetyl(hydroxy)amino]-1-carboxypentyl]amino]-2-oxoethyl]-2-hydroxy-4-oxobutanoic acid
(8s,16s)-3,12,21-trihydroxy-2,10,14,22-tetraoxo-3,9,15,21-tetraazatricosane-8,12,16-tricarboxylicacid
3,9,15,21-tetraazatricosane-8,12,16-tricarboxylic acid, 3,12,21-trihydroxy-2,10,14,22-tetraoxo-, (8s,16s)-
AKOS040750155

Research Excerpts

Overview

Aerobactin appears to be an important contributor to extracellular pathogenesis (mostly, that of Escherichia coli strains causing septicaemia and urinary tract infections) Aerobactins may play a role in the growth of intracellular pathogens like Shigella.

ExcerptReferenceRelevance
"Aerobactin appears to be an important contributor to extracellular pathogenesis (mostly, that of Escherichia coli strains causing septicaemia and urinary tract infections) and to the extracellular stages of growth of intracellular pathogens like Shigella."( Aerobactin production as a virulence factor: a reevaluation.
de Lorenzo, V; Martinez, JL, 1988
)
2.44

Effects

ExcerptReferenceRelevance
"Aerobactin has recently been demonstrated to play a pivotal role in mediating the enhanced virulence of a particularly invasive pathotype of Klebsiella pneumoniae (hvKP)."( Structural and Functional Characterization of Aerobactin Synthetase IucA from a Hypervirulent Pathotype of Klebsiella pneumoniae.
Bailey, DC; Drake, EJ; Grant, TD; Gulick, AM, 2016
)
1.41

Actions

ExcerptReferenceRelevance
"Aerobactin, probably because it is repeatedly reusable, efficiently stimulated bacterial growth at external concentrations some 500-fold lower than those of enterochelin."( Iron, siderophores, and the pursuit of virulence: independence of the aerobactin and enterochelin iron uptake systems in Escherichia coli.
Carbonetti, NH; Williams, PH, 1986
)
1.23

Bioavailability

ExcerptReferenceRelevance
"Iron is an essential element for oceanic microbial life but its low bioavailability limits microorganisms in large areas of the oceans."( Detection of photoactive siderophore biosynthetic genes in the marine environment.
Amin, SA; Carrano, CJ; Gärdes, A; Green, DH; Romano, A; Triana, C; Trimble, L, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
siderophoreAny of low-molecular-mass iron(III)-chelating compounds produced by microorganisms for the purpose of the transport and sequestration of iron.
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
virulence factorAny toxin secreted by bacteria, viruses, fungi or protozoa enabling them to achieve colonisation of a niche in the host, inhibit or evade the host's immune response, enter and exit cells, or obtain nutrition from the host.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
L-lysine derivativeA proteinogenic amino acid derivative resulting from reaction of L-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-lysine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (264)

TimeframeStudies, This Drug (%)All Drugs %
pre-199079 (29.92)18.7374
1990's96 (36.36)18.2507
2000's43 (16.29)29.6817
2010's37 (14.02)24.3611
2020's9 (3.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.65 (24.57)
Research Supply Index5.60 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews17 (6.32%)6.00%
Case Studies3 (1.12%)4.05%
Observational1 (0.37%)0.25%
Other248 (92.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]